Table 9.
Serovar | Multidrug | |||||||
---|---|---|---|---|---|---|---|---|
Resistant to >5 antimicrobials | ACSSuT1 | ACSSuTAuCx2 | ACT/S3 | |||||
Newport | 22 | 17.2% | 22 | 20.6% | 22 | 66.7% | 4 | 36.4% |
Typhimurium | 76 | 59.4% | 68 | 63.6% | 7 | 21.2% | 4 | 36.4% |
Heidelberg | 6 | 4.7% | 1 | 0.9% | ||||
Dublin | 3 | 2.3% | 3 | 2.8% | 3 | 9.1% | 1 | 9.1% |
I 4, [5], 12:i:- | 3 | 2.3% | 1 | 0.9% | ||||
Infantis | 1 | 0.8% | 1 | 0.9% | 1 | 3.0% | ||
Cubana | 2 | 1.6% | 1 | 0.9% | 1 | 9.1% | ||
Concord | 2 | 1.6% | ||||||
Denver | 1 | 0.8% | ||||||
Kentucky | 2 | 1.6% | ||||||
Choleraesuis | 2 | 1.6% | 1 | 0.9% | 1 | 9.1% | ||
Paratyphi B | 7 | 5.5% | 7 | 6.5% | ||||
Unknown | 1 | 0.8% | 1 | 0.9% |
1ACSSuT: ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline.
2ACSSuTAuCx: ACSSuT, amoxicillin-clavulanic acid, and ceftriaxone.
3ACT/S: ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.